Protective effects of magnesium sulfate against doxorubicin induced cardiotoxicity in rats
-
Add time:09/07/2019 Source:sciencedirect.com
AimsClinical use of doxorubicin, an effective chemotherapeutic agent, has limited uses due to dose-dependent cardiac toxicity. It has been supposed that the production of free radicals and calcium ions overload can lead to cardiac toxicity. Magnesium is a cardioprotective drug which inhibits lipid peroxidation and reducing myocardial apoptosis. This study was aimed to explore the hypothesis that the cardiac toxicity induced by administration of doxorubicin is prevented or reduced by magnesium sulfate treatment and if so, whether this is associated with altered oxidative stress response in heart.
We also recommend Trading Suppliers and Manufacturers of Magnesium peroxide (cas 1335-26-8). Pls Click Website Link as below: cas 1335-26-8 suppliers
Prev:Can magnesium reduce central neurodegeneration in Alzheimer's disease? Basic evidences and research needs
Next:Zeta potentials and sizes of aluminum salt precipitates – Effect of anions and organics and implications for coagulation mechanisms) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Can magnesium reduce central neurodegeneration in Alzheimer's disease? Basic evidences and research needs09/06/2019
- Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin09/05/2019
- Evaluation of lipid peroxidation and antioxidant defense mechanisms in the bone of rats in conditions of separate and combined administration of vanadium (V) and magnesium (Mg)09/04/2019
- Technical NotePolychlorinated biphenyls-containing electrical insulating oil contaminated soil treatment with calcium and Magnesium peroxide (cas 1335-26-8)s09/03/2019
- Fabrication of superhydrophobic magnesium alloy through the oxidation of hydrogen peroxide09/02/2019
- Evaluation of lipid peroxidation and the level of some elements in rat erythrocytes during separate and combined vanadium and magnesium administration09/01/2019
- Bulk and surface properties of Magnesium peroxide (cas 1335-26-8) MgO208/31/2019
- Application of encapsulated Magnesium peroxide (cas 1335-26-8) (MgO2) nanoparticles in permeable reactive barrier (PRB) for naphthalene and toluene bioremediation from groundwater08/30/2019
-
Health and Chemical more >


